Daily Archives: March 29, 2012

Medicare feels evidence on DME Drugs not sufficient to support use

Vascular endothelial growth factor (VEGF) inhibitors, such as ranibizumab (Lucentis) or bevacizumab (Avastin), may enhance vision in patients with diabetic macular edema (DME), but more research on specific risks and benefits is required according to a Medicare Insurance plan advisory … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , | Comments Off

Medicare Recipients Subscribe to Medicare Advantage Plans to battle diminished Wages.

In all the states Medicare recipients in every state are coming to terms with reduced retirement savings and the effect of the economic downturn. Medicare recipients consist of elderly people over age 65, people aging into Medicare health insurance at … Continue reading

Posted in Uncategorized | Tagged , , , , , , , , , , , , , , | Comments Off